Pendopharm https://pendopharm.beauvoir.dev/ Mon, 01 Dec 2025 18:51:40 +0000 en-CA hourly 1 https://wordpress.org/?v=7.1 Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for T\CBuccolam® in Canada and announces its authorization by Health Canada. https://pendopharm.beauvoir.dev/news/pendopharmmd-signe-un-accord-de-distribution-exclusif-avec-neuraxpharm-pour-prbuccolammd-au-canada-et-annonce-son-approbation-par-sante-canada/ Mon, 04 Aug 2025 15:09:42 +0000 https://pendopharm.com/?p=1900 MONTREAL, Canada, August 4th, 2025 – Pendopharm, a division of Pharmascience Inc., is pleased to announce that it has entered into an…

The post Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for T\CBuccolam® in Canada and announces its authorization by Health Canada. appeared first on Pendopharm.

]]> Pendopharm® and KalVista® Partner to Bring First Oral On-Demand HAE Treatment to Canada https://pendopharm.beauvoir.dev/news/pendopharm-and-kalvista-partner-to-bring-first-oral-on-demand-hae-treatment-to-canada/ Thu, 26 Jun 2025 21:21:11 +0000 https://pendopharm.com/?p=1875 Montreal, June 26th, 2025 – Pendopharm®, a division of Pharmascience Inc., has entered into an exclusive distribution agreement with KalVista Pharmaceuticals,…

The post Pendopharm® and KalVista® Partner to Bring First Oral On-Demand HAE Treatment to Canada appeared first on Pendopharm.

]]> Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)   https://pendopharm.beauvoir.dev/news/pendopharm-announces-public-drug-coverage-plan-listings-for-octasa-oral-mesalamine/ Mon, 09 Sep 2024 17:00:00 +0000 https://pendopharm.com/?p=1814 MONTREAL, Canada, September 9th, 2024 – Pendopharm, a division of Pharmascience Inc., is pleased to announce that Octasa® 800 mg and Octasa®…

The post Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)   appeared first on Pendopharm.

]]> Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada https://pendopharm.beauvoir.dev/news/pendopharm-signs-exclusive-distribution-agreement-with-ascendis-pharma-a-s-for-transcon-pth-in-canada/ Tue, 09 Jul 2024 21:34:57 +0000 https://pendopharm.com/?p=1794 Montreal, July 9, 2024 – Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement…

The post Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada appeared first on Pendopharm.

]]> Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc® https://pendopharm.beauvoir.dev/news/pendopharm-renews-distribution-agreement-with-anika-therapeutics-inc-for-cingal-monovisc-and-orthovisc/ Thu, 16 May 2024 15:00:00 +0000 https://pendopharm.com/?p=1766 MONTREAL, May 16, 2024 – Pendopharm, a division of Pharmascience Canada (“Pendopharm”), is pleased to announce the renewal of its exclusive…

The post Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc® appeared first on Pendopharm.

]]>